Commonly prescribed include:
- Aspirin
- Clopidogrel (Plavix®)
- Dipyridamole
- Prasugrel (Effient)
- Ticagrelor (Brilinta)
What the Medication Does:
Keeps blood clots from forming by preventing blood platelets from sticking together.
Reason for Medication:
- Helps prevent clotting in patients who have had a heart attack, unstable angina, ischemic strokes, TIA(transient ischemic attacks, or "little strokes") and other forms of cardiovascular disease.
- Usually prescribed preventively when plaque buildup is evident but there is not yet a major obstruction in the artery.
- Certain patients will be prescribed aspirin combined with another antiplatelet drug – also known as dual antiplatelet therapy (DAPT).
Dual Antiplatelet Therapy (DAPT):
Patients who have had heart attacks, patients who are treated with stents in their coronary arteries, and some patients who undergo coronary artery bypass graft surgery (CABG) are treated at the same time with two types of antiplatelet agents to prevent blood clotting. This is called dual antiplatelet therapy (DAPT).
One antiplatelet agent is aspirin. Almost everyone with coronary artery disease, including those who have had a heart attack, stent, or CABG are treated with aspirin for the rest of their lives. A second type of antiplatelet agent, called a P2Y12 inhibitor, is usually prescribed for months or years in addition to the aspirin therapy.
The type of medication and the duration of your treatment will vary based on a discussion with your healthcare provider weighing the risks of potential bleeding complications.
- If you did not have a heart attack, but have atherosclerosis in your coronary arteries and had a stent placed, you should be on clopidogrel for at least 1-6 months, depending on the type of stent which was placed, risk of clotting the stent, and bleeding risk.
- If you had a heart attack and a coronary artery stent placed, or you are being medically managed for your heart attack (specifically non-ST elevation myocardial infarction (NSTEMI), you should be on a P2Y12 inhibitor for approximately 6-12 months. In some cases, it may be advisable to be on DAPT for a longer duration. This will need to be discussed with your healthcare provider. There are three P2Y12inhibitors that doctors prescribe, which are clopidogrel, prasugrel, and ticagrelor. Studies have shown that two of these drugs (ticagrelor, prasugrel) are “stronger” than clopidogrel, and are a little better at decreasing the complications of blood clots. These two stronger agents, however, slightly increase bleeding. One of these drugs (prasugrel) should not be used by patients who have had a stroke or a transient ischemic attack (TIA). Which one these medications your doctor prescribes will be based on what he or she feels is best for you, based on your risk of blood clots and bleeding. For example, according to the FDA, clopidogrel does decrease the risk of stroke and MI, but does not change the risk of death for specific patients. So, the choice of what type of medication, cost of the medication and duration of treatment will be determined in conjunction with your healthcare provider.
- Some patients who undergo coronary artery bypass surgerymay be treated with a P2Y12 inhibitor for a year after the bypass operation. After this, the P2Y12 inhibitor may be stopped, but the patient continues on aspirin. Your surgeon will discuss if this treatment will be needed.
These are general recommendations for the duration and type of dual anti-platelet therapy which should be used after coronary artery stenting, heart attack and CABG. Again, it is important to talk to your doctor about your specific treatment plan.